Therefore, we sought to assess the clinical correlation between the number of CD4+CD25-CD69+ T cells in donor bone marrow and leukemia relapse after allo-HSCT, and we also performed a preliminary exploration into the potential immune mechanism responsible for this association. This evidence concerns the gene CD69 and leukemia.